📣 BIG NEWS FOR SICKLE CELL AWARENESS!

🩸🏈 Genetix Biotherapeutics and the National Football League Alumni Association have announced a new national partnership focused on increasing awareness of sickle cell disease and helping individuals and families better understand available treatment options and support resources. Through this partnership, former and current NFL voices will help elevate personal stories, support local community engagement, and connect families with educational resources—including information about newer transformative treatment options such as gene therapy. Sickle cell disease impacts approximately 100,000 people in the United States, yet far too many families still face gaps in awareness, access to information, and understanding of the rapidly changing treatment landscape. At the MTS Sickle Cell Foundation, we know that awareness must go beyond simply knowing that sickle cell disease exists. It means ensuring warriors and families have access to credible information, understand their options, know the questions to ask, and are empowered to make informed decisions about their care. The visibility that comes with a national platform like the NFL Alumni Association has the potential to bring sickle cell conversations into communities and households that have historically not received enough attention. We are encouraged to see this kind of investment in education and community engagement and look forward to seeing how this initiative helps move awareness—and ultimately access—forward. Every family deserves to know what is possible. ❤️ READ MORE HERE: https://www.businesswire.com/news/home/20260818166117/en/Genetix-Biotherapeutics-and-the-National-Football-League-Alumni-Association-Announce-Partnership-to-Increase-Awareness-for-Sickle-Cell-Disease-and-Transformative-Treatment-Options #SickleCellDisease #SickleCellAwareness #SickleCell #GeneTherapy #PatientEducation